{"id":"https://openalex.org/W62740511","doi":"https://doi.org/10.1007/978-3-7091-8755-5_4","title":"VP 16-213 in der Behandlung akuter myeloischer Leuk\u00e4mien bei Erwachsenen","display_name":"VP 16-213 in der Behandlung akuter myeloischer Leuk\u00e4mien bei Erwachsenen","publication_year":1984,"publication_date":"1984-01-01","ids":{"openalex":"https://openalex.org/W62740511","doi":"https://doi.org/10.1007/978-3-7091-8755-5_4","mag":"62740511"},"language":"de","primary_location":{"id":"doi:10.1007/978-3-7091-8755-5_4","doi":"https://doi.org/10.1007/978-3-7091-8755-5_4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-7091-8755-5_4","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Etoposid (VP 16-213) in der Therapie maligner Erkrankungen","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2489931611","display_name":"Etoposid (VP 16-213) in der Therapie maligner Erkrankungen"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111550011","display_name":"Dieter Lutz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101126","display_name":"Hanusch Hospital","ror":"https://ror.org/0163qhr63","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210101126"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"D. Lutz","raw_affiliation_strings":["III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria","institution_ids":["https://openalex.org/I4210101126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112488868","display_name":"O. Krieger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101126","display_name":"Hanusch Hospital","ror":"https://ror.org/0163qhr63","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210101126"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"O. Krieger","raw_affiliation_strings":["III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria","institution_ids":["https://openalex.org/I4210101126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110067871","display_name":"Raimund Waldner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101126","display_name":"Hanusch Hospital","ror":"https://ror.org/0163qhr63","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210101126"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"R. Waldner","raw_affiliation_strings":["III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria","institution_ids":["https://openalex.org/I4210101126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014500556","display_name":"G Linemayr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101126","display_name":"Hanusch Hospital","ror":"https://ror.org/0163qhr63","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210101126"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"G. Linemayr","raw_affiliation_strings":["III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III. Medizinische Abteilung und Ludwig Boltzmann-Institut f\u00fcr Leuk\u00e4mieforschung und H\u00e4matologie, Hanusch-Krankenhaus, Wien, Austria","institution_ids":["https://openalex.org/I4210101126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210101126"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.06642729,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"49","last_page":"55"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.12890000641345978,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.06809999793767929,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.7699999809265137},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.8040000200271606},{"id":"https://openalex.org/keywords/antimitotic-agents","display_name":"antimitotic agents","score":0.5199999809265137},{"id":"https://openalex.org/keywords/nucleoside-transport-inhibition","display_name":"nucleoside transport inhibition","score":0.7609999775886536},{"id":"https://openalex.org/keywords/dna-synthesis-inhibition","display_name":"DNA synthesis inhibition","score":0.8220000267028809},{"id":"https://openalex.org/keywords/g2-cell-cycle-arrest","display_name":"G2 cell cycle arrest","score":0.6669999957084656},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.5529999732971191},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.4449999928474426},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.5201069116592407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4236871600151062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39547020196914673},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3622596859931946},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07894644141197205}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-3-7091-8755-5_4","doi":"https://doi.org/10.1007/978-3-7091-8755-5_4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-3-7091-8755-5_4","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Etoposid (VP 16-213) in der Therapie maligner Erkrankungen","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W189777513","https://openalex.org/W2028309254","https://openalex.org/W2039768273","https://openalex.org/W2066805950","https://openalex.org/W2078710130","https://openalex.org/W2080284625","https://openalex.org/W2145341422","https://openalex.org/W2152674904","https://openalex.org/W2171537264","https://openalex.org/W2298381191","https://openalex.org/W2395890015","https://openalex.org/W2403091162","https://openalex.org/W2407845740","https://openalex.org/W2409005554","https://openalex.org/W2411150720","https://openalex.org/W4214838816"],"related_works":["https://openalex.org/W2152674904","https://openalex.org/W2317745048","https://openalex.org/W2883411240","https://openalex.org/W2100875935","https://openalex.org/W1603285299","https://openalex.org/W2090807692","https://openalex.org/W1568938857","https://openalex.org/W2950249768","https://openalex.org/W1974180817","https://openalex.org/W2404274201"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}